Karen Knudsen,/LinkedIn
Jun 1, 2025, 02:56
Karen Knudsen: Happy to Meet with My Former Trainee, Emily Bosco
Karen Knudsen, CEO of Parker Institute for Cancer Immunotherapy, shared a post on LinkedIn:
“There’s nothing better than meeting up with former trainees who are truly flourishing in their careers, and in the case of Emily E. Bosco, blazing incredible new trails at AstraZeneca for treating advanced prostate cancer.
So wonderful to spend the last several days with brilliant AZ leaders. Next stop, ASCO !”
More posts featuring ASCO25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 19, 2025, 20:26
Jul 19, 2025, 20:21
Jul 19, 2025, 20:00
Jul 19, 2025, 19:47